Furthermore, the loss of tumor suppressors such as phosphatase and tensin homolog (PTEN) and neurofibromin 1 (NF1) is linked to aberrant NF-κB activation in GBM, resulting in enhanced PI3-kinase activity. The gene discussed is NFKB1; the disease is glioblastoma.